MoneyWorks4Me

Windlas Biotech informs about transcript of conference call

09 Nov 2021 Evaluate

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Windlas Biotech has informed that it attached Q2 FY22 Earnings Conference Call Transcript.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1810.00
Dr. Reddys Labs. 1200.10
Cipla 1346.85
Lupin 2029.00
Zydus Lifesciences 1145.25
View more..